Medical Research News

RSS

A novel assay for the rapid detection of SARS-CoV-2 variants

A new study discusses a new assay method designed by researchers to identify SARS-CoV-2 variants.

20 Jan 2022

Virucidal effect of UV and violet light on SARS-CoV-2

In a recent study published in the Journal of Photochemistry and Photobiology, a team of researchers analyzed the effect of ultraviolet (UV) and violet light of different wavelengths on the virulence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 Jan 2022

Researchers compare two psychotherapies used for treating veterans with PTSD

Cognitive processing therapy and prolonged exposure are the two leading trauma-focused cognitive behavioral psychotherapies used for Veterans Affairs patients with PTSD.

20 Jan 2022

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.

20 Jan 2022

Study reveals the limitations of manipulating emotional responses to counter distressing moments

A study from the University of Ottawa's Faculty of Social Sciences has revealed the limitations of manipulating emotional responses to counter distressing moments, with participants – particularly women – relying on spontaneous regulated emotion rather than a forced response to cope.

20 Jan 2022

Study finds no proof of recently infected mothers transmitting SARS-CoV-2 through breastmilk

There is no evidence of recently infected mothers transmitting infectious SARS-CoV-2 through breastmilk to their baby, reports a study published in the journal Pediatric Research.

20 Jan 2022

Females more prone to long-term post-COVID-19 symptoms

In a recent study published in the Journal of Clinical Medicine, researchers described the results of a multi-center study (LONG-COVID-EXP-CM) that investigated sex differences in coronavirus disease 2019 (COVID-19)-related symptoms and long-term post-COVID-19 symptoms in a group of previously hospitalized COVID-19 survivors in a large Spanish population.

19 Jan 2022

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Researchers investigate the cross-reactivity of the SARS-CoV-2 with pre-pandemic malaria-exposed sera samples collected from Cambodia.

19 Jan 2022

How does SARS-CoV-2 infection impact female fertility?

In a recent study published in the journal International Journal of Environmental Research and Public Health, a team of researchers reviewed published literature that assessed the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female reproductive health.

19 Jan 2022

Positive childhood environments may help buffer the physiological effects of adversity and trauma

Researchers know that experiencing a high number of adverse events in childhood correlates with worse health outcomes in adulthood. These studies have led to an emphasis on trauma-informed practice in schools and workplaces in an attempt to mitigate the harm of early adversity.

19 Jan 2022

SARS-CoV-2 RNA can be detected in exhaled aerosol

In a study published in the open-access journal Influenza and other Respiratory Viruses, researchers investigated if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be detected in exhaled aerosol samples obtained from coronavirus disease 2019 (COVID-19) patients during many different types of breathing and coughing. They also analyzed how SARS-CoV-2 infection may affect the size and number of exhaled aerosol particles.

19 Jan 2022

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10% of patients surviving longer than five years after diagnosis.

19 Jan 2022

Exploring the interactions between multiple respiratory viruses

A recent report explores the dynamics of viral interference between various respiratory viruses in light of the ongoing COVID-19 pandemic.

19 Jan 2022

Researchers develop nanotherapeutic drug to prevent cancer from spreading to the liver

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver in mice.

19 Jan 2022

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

The most comprehensive estimate of the global impact of antimicrobial resistance thus far is published in The Lancet today. It reveals that more than 1.2 million people (and potentially millions more) around the world died in 2019 as a direct result of antibiotic-resistant bacterial infections – placing it among the leading causes of death.

19 Jan 2022

Research highlights unmet care needs among older parents in biological and stepfamilies

As people age and require more care, their partners or adult children are often their front line of caretakers.

19 Jan 2022

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

A new study discusses the targeted discovery of NTD-reactive antibodies from an individual who had recovered from SARS-CoV-2 infection.

19 Jan 2022

'Retinal age gap' can be an independent predictor of increased mortality risk

The difference between the biological age of the retina, the light sensitive layers of nerve tissue at the back of the eye, and a person's real (chronological) age, is linked to their risk of death, finds research published online in the British Journal of Ophthalmology.

19 Jan 2022

Waiting more than 5 hours in emergency care before admission may increase mortality risk

Waiting more than 5 hours in emergency care before admission to hospital is linked to a heightened risk of death from any cause within the next 30 days, reveals a study of more than 5 million patients in England and published online in the Emergency Medicine Journal.

19 Jan 2022

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

A growing body of evidence indicates that some people thought to have an allergic response to injectable penicillin, the standard treatment for rheumatic heart disease, may instead be experiencing a cardiac reaction to the medicine, according to a new American Heart Association presidential advisory published today in Journal of the American Heart Association.

19 Jan 2022

Medical Research News

A novel assay for the rapid detection of SARS-CoV-2 variants

Virucidal effect of UV and violet light on SARS-CoV-2

Researchers compare two psychotherapies used for treating veterans with PTSD

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Study reveals the limitations of manipulating emotional responses to counter distressing moments

Study finds no proof of recently infected mothers transmitting SARS-CoV-2 through breastmilk

Females more prone to long-term post-COVID-19 symptoms

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

How does SARS-CoV-2 infection impact female fertility?

Positive childhood environments may help buffer the physiological effects of adversity and trauma

SARS-CoV-2 RNA can be detected in exhaled aerosol

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Exploring the interactions between multiple respiratory viruses

Researchers develop nanotherapeutic drug to prevent cancer from spreading to the liver

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

Research highlights unmet care needs among older parents in biological and stepfamilies

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

'Retinal age gap' can be an independent predictor of increased mortality risk

Waiting more than 5 hours in emergency care before admission may increase mortality risk

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News